Javitt Jonathan C insider trades
Javitt Jonathan C has filed 7 Form 4s with the SEC that we hold, all for NRX Pharmaceuticals, Inc. (NRXP), as Chairman and Chief Scientist, Director, 10% owner. Across all of them we count 5 purchases worth $6.0M and 1 sale worth $400.0K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 100,000 shares of NRX Pharmaceuticals, Inc. worth $5.8M, dated 2022-06-01. The first filing on our record is dated 2022-06-02 and the latest 2025-09-10.
NRX Pharmaceuticals, Inc. (NRXP)
Chairman and Chief Scientist, Director, 10% owner · 8 filings · 6 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-06-01 | P, purchase reported on Form 4 | 100,000 | $58.0K | 2022-06-02 | SEC |
| 2022-06-01 | P, purchase reported on Form 4 | 100,000 | $5.8M | 2022-06-02 | SEC |
| 2022-12-07 | S, sale reported on Form 4 | 400,000 | $400.0K | 2022-12-09 | SEC |
| 2023-08-22 | P, purchase reported on Form 4 | 200,000 | $64.0K | 2023-08-23 | SEC |
| 2023-08-23 | P, purchase reported on Form 4 | 100,000 | $33.0K | 2023-08-24 | SEC |
| 2024-12-17 | P, purchase reported on Form 4 | 40,000 | $46.8K | 2024-12-18 | SEC |
Source
Counted from the Form 4 filings this reporting owner (SEC CIK 1303782) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
